O-1871

O-1871_structure.png

O-1871 is a synthetic cannabinoid that is structurally related to tetrahydrocannabinol (THC), the primary psychoactive component of cannabis. It is part of a class of compounds known as cannabinoids, which interact with the endocannabinoid system in the body.

Chemical Structure

O-1871 has the IUPAC name (6aR,10aR)-3-(hydroxymethyl)-6,6-dimethyl-9-pentyl-6a,7,10,10a-tetrahydro-6H-benzo[c]chromen-1-ol. Its chemical structure is similar to that of THC, with modifications that include a hydroxymethyl group and a pentyl side chain.

Pharmacology

O-1871 acts on the cannabinoid receptors in the central nervous system and peripheral nervous system. These receptors are part of the endocannabinoid system, which plays a role in regulating various physiological processes including pain, mood, and appetite.

Research and Applications

Research on O-1871 is primarily focused on its potential therapeutic applications and its effects on the endocannabinoid system. Studies have investigated its potential use in treating conditions such as chronic pain, inflammation, and neurological disorders.

Legal Status

The legal status of O-1871 varies by country. In some jurisdictions, it may be classified as a controlled substance due to its structural similarity to THC and its potential for psychoactive effects.

See Also

• Cannabinoid
• Tetrahydrocannabinol
• Endocannabinoid system
• Synthetic cannabinoids

References

‎